CIM
GH icon

Contravisory Investment Management’s Guardant Health GH Stock Holding History

Contravisory Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Hold
124
– – ﹤0.01% 312
2026
Q1 		$11.5K Hold
124
– – ﹤0.01% 341
2025
Q4 		$12.7K Buy
+124
New +$11.1K ﹤0.01% 327

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Contravisory Investment Management's GH Position: Q2 2026 in Review

Contravisory Investment Management held its Guardant Health (GH) position steady in Q2 2026 at 124 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Contravisory Investment Management first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Contravisory Investment Management held 124 shares of Guardant Health worth $18.6K as of Q2 2026.
  • Contravisory Investment Management left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Contravisory Investment Management's portfolio in Q2 2026, its #312 holding.
  • Contravisory Investment Management first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.